InvestorsHub Logo
Followers 14
Posts 2863
Boards Moderated 0
Alias Born 12/23/2014

Re: Jlivermore29 post# 43

Friday, 11/15/2019 4:57:28 PM

Friday, November 15, 2019 4:57:28 PM

Post# of 461
@J Good find. My first reaction is that the home infusion device being shown is scary. It looks like a children's water gun pump toy.

What I sense is that you see some potential head winds to KRMD's growth? What I see is possible(?) growing pains that will be worked through as companies, such as Grifols, reconfigure drugs for subq. The growing pains are symptomatic of rapid market expansion.


https://www.pharmaceutical-technology.com/news/fda-approves-grifols-xembify-for-immunodeficiencies/
"Grifols plans to launch Xembify in the US in the second quarter of this year. It is also seeking approvals in Canada and Europe."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent KRMD News